Company intelligence / Profile preview

empowerDX

Framingham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

empowerDX is a direct-to-consumer health testing company that provides a wide range of at-home collection kits. As a subsidiary of Eurofins Scientific, the company leverages a global network of clinical laboratories to offer physician-reviewed tests for COVID-19, women's health, genetic predispositions, and environmental exposures like PFAS. Their service model focuses on making clinical-grade diagnostics accessible and convenient for individuals without requiring an in-person doctor's visit. The company's portfolio includes specialized tests for gut health, mental health markers, and metabolic function.

Therapeutic areas: ImmunologyOtherEndocrinologyInfectious DiseasesGastroenterologyMetabolic Disorders
Modalities: Diagnostic TestPolymerase chain reactionNext-generation sequencingEnzyme-linked immunosorbent assay
Industry: Molecular Diagnostics

Partnerships

Eurofins Clinical Diagnostics

Beyond the preview

Go deeper on empowerDX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on empowerDX.

Explore the full profile